Novacyt Financing PR ENG (20-06-17) FINAL Momentum towards profitability continues through H1 2017 Investing to support increased sales demand across business
Visit PageYear: 2017
NOVACYT FULL YEAR 2016 RESULTS DELIVER DOUBLE DIGIT SALES GROWTH Strong start to 2017 accelerating trajectory towards profitability
Novacyt FY16 financial results PR ENG Paris, France and Cambridge, UK – 27 April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its financial results for the year ended 31 December 2016.
Visit PageNovacyt Announces Bond Issue
Novacyt – Announces Bond Issue ENG Paris, France and Cambridge, UK – 6th April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces the Company has issued a convertible bond in the amount of €1,500,000 through the issuance of 1,500,000 bonds which are convertible into shares with a nominal value of
Visit Page